世界の血管パッチ市場

出版：BCC Research（BCCリサーチ）　出版年月：2023年4月

Global Vascular Patches Market
世界の血管パッチ市場

レポート目次　　お問合せ・ご注文　　価格・納期について

Report Highlights

The global vascular patches market reached $717.4 million in 2022 and should reach $1 billion by 2027, with a compound annual growth rate (CAGR) of 7.1% during the forecast period of 2022-2027.

Summary:

Vascular patches play an increasingly important role in the treatment of cardiovascular diseases for several reasons, including the increasing prevalence and incidences of chronic heart diseases. These factors are anticipated to augment the demand for vascular patches during the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), around REDACTED million adults aged REDACTED and older have coronary artery disease (CAD) in 2020. Similarly, REDACTED million adults were diagnosed with heart disease in the U.S. in 2018.

Inorganic strategies among market players are also boosting the vascular patch market. For instance, In 2019, LeMaitre Vascular Inc., a manufacturer of devices for the treatment of peripheral vascular diseases, purchased the CardiCel and VascuCel patch business from Australian biotech company Admedus Ltd. (now known as Anteris Technologies), for $REDACTED million. The companies also signed a license agreement for tissue processing technology restricted to the CardioCel and VascuCel lines.

Other factors, such as innovation, technological advances and the launch of novel products from market players, are expected to increase demand for vascular patches during the forecast period. However, during this time, limitations of vascular patches and product recalls may impede market growth. Leaders in the vascular patch market include Johnson & Johnson MedTech, Edwards Lifesciences Corp., B. Braun Melsungen AG, Getinge AB, Baxter, W. L. Gore & Associates, LeMaitre Vascular and Artivion.

The global market for vascular patches was valued at $REDACTED million in 2020. The market is expected to grow at a CAGR of REDACTED% to reach over $REDACTED billion by the end of 2027. The growth of the global market is attributed to factors such as the rise in the incidence of cardiovascular diseases, the growing adoption of biological patches, and an increase in the geriatric population. In this report, the global market for vascular patches is segmented based on patch type, application and region.

Report Scope:

This report analyzes the trends in the vascular patch market with data from 2021, estimates from 2022, projections of compound annual growth rates (CAGRs) through the forecast period of 2022 to 2027), and regional markets. This report highlights the current and future market potential of vascular patches and provides a detailed analysis of the competitive landscape. The report covers regulatory scenarios, drivers, restraints, and opportunities. The report also offers market projections for 2027 and provides the market shares for key companies.

The market in this report is segmented by type, application and region. The type of patch is further segmented into biological and synthetic vascular patches. Applications include carotid endarterectomy, aortic aneurysms, profundaplasty, surgical patch angioplasty and vascular bypass surgery.

For the regional market analysis, the global market has been segmented into the key regions of North America, Europe, Asia-Pacific and Rest of the World. Detailed analyses of specific countries, such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India, are provided. For market estimates, data is provided for 2021 as the base year, with forecasts for 2022 and forecast values for 2027.

Report Includes:

– 18 data tables and 19 additional tables
– An overview of the global market for vascular patches
– Estimation of the market size and analyses of global market trends, with data from 2021, 2022 and projections of compound annual growth rates (CAGRs) through 2027
– Characterization and quantification of market potential for vascular patches by application, type, and region
– Brief description about various processes such as carotid endarterectomy, aortic aneurysms, profundaplasty, surgical patch angioplasty and vascular bypass surgery, and discussion on type and material of vascular patches to be used for the particular process
– Discussion on advantages and drawbacks of biological vascular patches and synthetic vascular patches, and their role in the treatment of cardiovascular diseases
– Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size and forecast, and technological advancements within the industry
– Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
– Company profiles of major players within the industry, including B. Braun SE, Baxter International Inc., Edwards Lifesciences, Johnson & Johnson Services Inc., and Terumo Corp.

目次

Table of Contents
Chapter 1 Introduction
1.1 Overview
1.2 Study Goals and Objectives
1.3 Reasons for Doing this Study
1.4 Scope of Report
1.5 Information Sources
1.6 Methodology
1.7 Geographic Breakdown
1.8 Analyst’s Credentials
1.9 BCC Custom Research
1.10 Related BCC Research Reports
Chapter 2 Summary and Highlights
2.1 Overview
Chapter 3 Market Dynamics
3.1 Market Drivers
3.1.1 Rising Prevalence of Cardiovascular Diseases Globally
3.1.2 Increasing Adoption of Biological Vascular Patches
3.1.3 Growing Geriatric Population and Changing Lifestyles
3.2 Market Restraints
3.2.1 Product Recalls
3.2.2 Limitations Associated with Vascular Patches and their Applications
3.3 Market Opportunities
3.3.1 Inorganic Strategies Among Market Players
Chapter 4 Market Overview
4.1 Market Overview
4.2 Current Market Trends
4.2.1 Currently Available Vascular Patches
4.3 Emerging Technologies
4.3.1 Products in the Pipeline
Chapter 5 Regulatory Landscape and Reimbursement Scenario
5.1 Regulatory Landscape
5.1.1 North America
5.1.2 Europe
5.1.3 Asia-Pacific
5.1.4 ASEAN Countries
5.2 Reimbursement Scenario
5.2.1 Pricing and Reimbursement Overview
5.2.2 U.S.
5.2.3 Europe
5.2.4 Asia-Pacific
Chapter 6 Impact of COVID-19 on the Market
6.1 Overview
6.1.1 COVID-19 Crisis
6.1.2 Impact of COVID-19 on Cardiovascular Diseases
6.1.3 Impact of COVID-19 on the Vascular Patch Market
6.1.4 COVID-19 Measures
Chapter 7 Market Breakdown by Patch Type
7.1 Types of Vascular Patches
7.1.1 Biologic Vascular Patches
7.1.2 Synthetic Vascular Patches
Chapter 8 Market Breakdown by Application
8.1 Applications for Vascular Patches
8.1.1 Carotid Endarterectomy
8.1.2 Aortic Aneurysms
8.1.3 Profundaplasty
8.1.4 Vascular Bypass Surgery
8.1.5 Vascular Repair and Reconstruction
Chapter 9 Market Breakdown by Region
9.1 Overview
9.1.1 North America
9.1.2 Europe
9.1.3 Asia-Pacific
9.1.4 Rest of the World
Chapter 10 Analysis of Market Opportunities
10.1 Porter’s Five Forces Analysis
10.1.1 Threat of New Entrants
10.1.2 Threat of Substitutes
10.1.3 Bargaining Power of Suppliers
10.1.4 Bargaining Power of Buyers
10.1.5 Degree of Competition
Chapter 11 Competitive Landscape
11.1 Company Share Analysis
11.1.1 Recent Developments in the Market for Vascular Patches
Chapter 12 Company Profiles
12.1 Major Companies
ARTIVION INC.
B. BRAUN SE
BAXTER INTERNATIONAL INC.
EDWARDS LIFESCIENCES CORP.
GETINGE AB
JOHNSON & JOHNSON MEDTECH
LABCOR LABORATÓRIOS LTDA.
LEMAITRE VASCULAR INC.
TERUMO CORP.
W. L. GORE & ASSOCIATES INC.
Chapter 13 Appendix: Abbreviations

List of Tables
Summary Table : Global Market for Vascular Patches, by Patch Type, Through 2027
Table 1 : Angina Pectoris and Stroke Survivors, Worldwide, Through 2030
Table 2 : Global Incidence and Prevalence of All Stroke Types, 2019
Table 3 : Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
Table 4 : Available Biological Vascular Patches in the Market
Table 5 : Complications of Carotid Endarterectomy (CEA) Surgeries
Table 6 : Vascular Patches Available on the Market
Table 7 : Medical Devices and Licensing Authority
Table 8 : Medical Devices and Licensing Authority for Newly Notified Medical Devices
Table 9 : Medical Devices Regulated/Proposed to be Regulated
Table 10 : Global Market for Vascular Patches, by Patch Type, Through 2027
Table 11 : Global Market for Biologic Vascular Patches, by Region, Through 2027
Table 12 : Global Market for Synthetic Vascular Patches, by Region, Through 2027
Table 13 : Global Market for Vascular Patches, by Application, Through 2027
Table 14 : Global Market for Vascular Patches in Carotid Endarterectomy, by Region, Through 2027
Table 15 : Global Market for Aortic Aneurysms, by Region, Through 2027
Table 16 : Global Market for Vascular Patches in Profundaplasty, by Region, Through 2027
Table 17 : Global Market for Vascular Patches in Vascular Bypass Surgery, by Region, Through 2027
Table 18 : Global Market for Vascular Patches in Vascular Repair and Reconstruction, by Region, Through 2027
Table 19 : Global Market for Vascular Patches, by Region, Through 2027
Table 20 : North American Market for Vascular Patches, by Country, Through 2027
Table 21 : European Market for Vascular Patches, by Country, Through 2027
Table 22 : Asia-Pacific Market for Vascular Patches, by Country, Through 2027
Table 23 : Rest of the World Market for Vascular Patches, by Region, Through 2027
Table 24 : Porter’s Five Forces Analysis
Table 25 : Recent Developments in the Market for Vascular Patches
Table 26 : Artivion Inc.: Vascular Patches
Table 27 : B. Braun SE: Vascular Patches
Table 28 : Baxter International Inc.: Vascular Patches
Table 29 : Edwards Lifesciences: Vascular Patches
Table 30 : Getinge AB: Vascular Patches
Table 31 : Johnson & Johnson MedTech: Vascular Patches
Table 32 : Labcor Laboratórios Ltda.: Vascular Patches
Table 33 : LeMaitre Vascular: Vascular Patches
Table 34 : Terumo Corp.: Vascular Patches
Table 35 : W. L. Gore & Associates Inc.: Vascular Patches
Table 36 : Abbreviations Used in This Report

List of Figures
Figure A : Global Vascular Patch Market
Summary Figure : Global Market Shares of Vascular Patches, by Patch Type, 2027
Figure 1 : Medical Device Marketing Process in the U.S.
Figure 2 : Possible Effect Mechanisms of the COVID-19 Pandemic on CVDs
Figure 3 : Global Market for Biologic Vascular Patches, by Type, 2019-2027
Figure 4 : Global Market for Synthetic Vascular Patches, by Type, 2019-2027
Figure 5 : Global Market for Vascular Patches in Carotid Endarterectomy, 2019-2027
Figure 6 : Global Market for Vascular Patches in Aortic Aneurysms, 2019-2027
Figure 7 : Global Market for Vascular Patches in Profundaplasty, 2019-2027
Figure 8 : Global Market for Vascular Patches in Vascular Bypass Surgery, 2019-2027
Figure 9 : Global Market for Vascular Patches in Vascular Repair and Reconstruction, 2019-2027
Figure 10 : Snapshot of Global Market for Vascular Patches, 2021
Figure 11 : Global Market Shares of Vascular Patches, by Region, 2021
Figure 12 : Snapshot of North American Market for Vascular Patches, 2021
Figure 13 : North American Market for Vascular Patches, by Country, 2020-2027
Figure 14 : Snapshot of European Market for Vascular Patches, 2021
Figure 15 : European Market for Vascular Patches, by Country, 2020-2027
Figure 16 : Snapshot of Asia-Pacific Market for Vascular Patches, 2021
Figure 17 : Asia-Pacific Market for Vascular Patches, by Country, 2019-2027
Figure 18 : Rest of the World Market for Vascular Patches, by Region, 2019-2027
Figure 19 : Global Market Shares of Vascular Patches, by Company, 2021
Figure 20 : Artivion Inc.: Annual Revenue, 2018–2021
Figure 21 : Artivion Inc.: Revenue Share, by Segment, 2021
Figure 22 : Artivion Inc.: Revenue, by Region, 2021
Figure 23 : B. Braun SE: Annual Revenue, 2018-2021
Figure 24 : B. Braun SE: Revenue Share, by Division, 2021
Figure 25 : B. Braun SE: Revenue, by Region, 2021
Figure 26 : Baxter International Inc.: Annual Revenue, 2018–2021
Figure 27 : Baxter International Inc.: Revenue Share, by Segment, 2021
Figure 28 : Baxter International Inc.: Revenue, by Region, 2021
Figure 29 : Edwards Lifesciences: Annual Revenue, 2018-2021
Figure 30 : Edwards Lifesciences: Revenue Share, by Product Areas, 2021
Figure 31 : Edwards Lifesciences: Revenue, by Region, 2021
Figure 32 : Getinge AB: Annual Revenue, 2018–2021
Figure 33 : Getinge AB: Revenue Share, by Product Area, 2021
Figure 34 : Getinge AB: Revenue, by Region, 2021
Figure 35 : Johnson & Johnson Services Inc.: Annual Revenue, 2018-2021
Figure 36 : Johnson & Johnson Services Inc.: Revenue Share, by Business Segment, 2021
Figure 37 : Johnson & Johnson Services Inc.: Revenue, by Region, 2021
Figure 38 : Terumo Corp.: Annual Revenue, 2018–2021
Figure 39 : Terumo Corp.: Revenue Share, by Business Segment, 2021